Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06698224 · ClinicalTrials.gov registry record · NA
Paired Spinal Cord and Peripheral Nerve Stimulation to Recover Hand Function in SCI
A NA study, sponsored by Kessler Foundation.
- Not yet
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT06698224: Clinical Trial NA study, sponsored by Kessler Foundation.
NCT06698224 is a NA study that has not yet begun recruiting, run by Kessler Foundation. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06698224, a NA study, has not yet begun recruiting, sponsored by Kessler Foundation.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Individuals who suffer a spinal cord injury in the neck region have difficulty using their hands due to paralysis and/or weakness of their arms and hand muscles. This project aims to test the effects of pairing spinal cord and nerve stimulation combined with physical therapy training in recovering arms and hand function. The long-term goal is to provide better therapies that will improve the ability of individuals with spinal cord injuries to use their arms and hands to perform everyday tasks, similar to injury before.
Primary Outcome
Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) is a 3-part assessment designed to measure participant's hand and arm function. The test specifically measures strength, sensation, and prehension. During strength testing, selected upper extremity muscles are assessed for the grade of muscle contraction or power of the muscle. During sensation testing, specific zones on the palmar and dorsal aspects of the hand are tested with Semmes Weinstein Monofilaments (SWM) with
Interventions
- DEVICE Spinal cord transcutaneous stimulation
- DEVICE Paired spinal cord and peripheral nerve stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2025-01-02 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
What is known before NCT06698224 opens enrollment
NCT06698224 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Spinal cord transcutaneous stimulation is the first listed.
NCT06698224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06698224 about?
NCT06698224 is a clinical study titled "Paired Spinal Cord and Peripheral Nerve Stimulation to Recover Hand Function in SCI". Individuals who suffer a spinal cord injury in the neck region have difficulty using their hands due to paralysis and/or weakness of their arms and hand muscles. This project aims to test the effects of pairing spinal cord and nerve stimulation combined with physical therapy training in recovering a...
What is the current status of trial NCT06698224?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2025-01-02. Estimated completion is 2026-11-01.
What interventions are being tested in trial NCT06698224?
The interventions under investigation include: Spinal cord transcutaneous stimulation (DEVICE), Paired spinal cord and peripheral nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT06698224?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06698224's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy